Hibernicor, LLC manufactures a heart preservation device, Asporto, that allows for the prolonged preservation of the donor heart in the context of cardiac transplantation. Hibernicor has finalized the pre-clnical research protocol necessary for 510k approval through the FDA and has received a humanitarian device exemption.
Additionally, Hibernicor developed Praesto, a pre-clinical electronic record system. This system was implimented in the Experimental Surgical Services at the University of Minnesota in 2008.
Company’s Keywords:
the world, medical device, heart preservation device, medical software, peristalitic pumps
<39
<6527000
<1&1 Email Provider, Apache, StatCounter, WordPress.org, Mobile Friendly, Google Font API, Vimeo, Google Maps
<2004
Your request has been submitted successfully.
Own or work here?